163
Views
4
CrossRef citations to date
0
Altmetric
Review

Synthesis of oleanolic acid analogues targeting PDGF receptor inhibitors and their antitumor biological activities

, , , , &
Pages 150-162 | Received 27 Jul 2019, Accepted 13 Jan 2020, Published online: 26 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Meng Yan-Qiu, Bei-Bei Meng, Dong-Ping Xu, Zhi-Qi Wang, Jin-Ming Li & Mei-Qi Huang. (2023) Design, synthesis, and anti-tumor activity of derivatives of ring A and C-28 of asiatic acid. Journal of Asian Natural Products Research 0:0, pages 1-13.
Read now
Meng Yan-Qiu, Jin-Ming Li, Zhi-Qi Wang, Dong-Ping Xu, Mei-Qi Huang & Bei-Bei Meng. (2023) Design, synthesis, and antitumor activity of novel oleanolic acid analogues targeting EGFR. Journal of Asian Natural Products Research 0:0, pages 1-14.
Read now
Yan-Qiu Meng, Zhi-Qi Wang, Jin-Ming Li, Dong-Ping Xu, Bei-Bei Meng & Mei-Qi Huang. (2023) Synthesis and anti-tumor activity of asiatic acid derivatives targeting VEGFR. Journal of Asian Natural Products Research 0:0, pages 1-12.
Read now

Articles from other publishers (1)

Yi-Hui Yang, Si-Yang Dai, Fu-Hua Deng, Li-Huan Peng, Chang Li & Yue-Hu Pei. (2022) Recent advances in medicinal chemistry of oleanolic acid derivatives. Phytochemistry 203, pages 113397.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.